Risks and benefits of hormone replacement therapy

July 1997

An important study in the latest NEJM sheds new light on the risks and benefits of hormone replacement therapy.

Estrogen use reduces mortality by about 40%...primarily by decreasing death from heart disease.

But the study shows this benefit declines after 10 years...because of an increase in mortality from breast cancer.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

New recommendations for preventing bacterial endocarditis
Lyme Disease Ceftin (cefuroxime) for Lyme disease
Lyme Disease Vaccine to prevent Lyme disease
Asthma New OTC device called Doser
Diabetes New recommendations for DIAGNOSING diabetes
Diabetes New guidelines for TREATING type 2 diabetes
Women's Health Raloxifene (Evista), a new "designer estrogen"
Women's Health Risks and benefits of hormone replacement therapy
Laxatives The stimulant laxative phenolphthalein will probably be taken off the market
New HIV protease inhibitors might increase blood sugar
New guidelines for treating HIV
Info about vaccines and medicines needed for international travel
What to use to prevent motion sickness
Loading up on creatine to boost performance
Pyruvate to enhance fat loss and improve endurance
Anticoagulants Two new anticoagulants just hit the market
Anticoagulants Orgaran (danaparoid) contains a substance that's similar to heparin...Heparan
Chronotherapeutics is a hot area right now